JP Morgan Chase
SPRB

JP Morgan Chase’s Spruce Biosciences SPRB Stock Holding History

JP Morgan Chase’s Portfolio SPRB Stock Details SPRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$63K Buy
+1,127
New +$63K ﹤0.01% 6330
2025
Q2 		– Sell
-1
Closed -$19 – 7848
2025
Q1 		$19 Hold
1
– – ﹤0.01% 7135
2024
Q4 		$29 Hold
1
– – ﹤0.01% 7223
2024
Q3 		$33 Hold
1
– – ﹤0.01% 7184
2024
Q2 		$38 Buy
+1
New +$54 ﹤0.01% 7072
2024
Q1 		– Hold
0
– – – 7244
2023
Q4 		– Hold
0
– – – 7272
2023
Q3 		– Sell
-314
Closed -$52.9K – 7128
2023
Q2 		$50.7K Sell
314
-462
-60% -$77.2K ﹤0.01% 5717
2023
Q1 		$129K Buy
+776
New +$144K ﹤0.01% 5316
2022
Q4 		– Hold
0
– – – 7081
2022
Q3 		– Hold
0
– – – 6931
2022
Q2 		– Sell
-1,512
Closed -$194K – 6966
2022
Q1 		$227K Sell
1,512
-66
-4% -$12.3K ﹤0.01% 5125
2021
Q4 		$528K Sell
1,578
-95
-6% -$28.3K ﹤0.01% 4791
2021
Q3 		$754K Sell
1,673
-512
-23% -$321K ﹤0.01% 4493
2021
Q2 		$1.84M Sell
2,185
-215
-9% -$229K ﹤0.01% 3852
2021
Q1 		$2.99M Sell
2,400
-118
-5% -$181K ﹤0.01% 3400
2020
Q4 		$4.59M Buy
+2,518
New +$4.17M ﹤0.01% 2882

Other funds holding SPRB

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return

JP Morgan Chase's SPRB Position: Q2 2026 in Review

JP Morgan Chase opened a new position in Spruce Biosciences (SPRB) in Q2 2026: 1,127 shares worth $63K. The stake represents ﹤0.01% of the portfolio and ranks #6330 among its holdings. This is a return to the name: JP Morgan Chase previously reported a position in SPRB as recently as Q1 2025.

JP Morgan Chase first reported a position in SPRB in Q4 2020 and has held it in 13 quarters since. The position peaked at $4.59M in Q4 2020. 63 funds tracked by Wall St. Rank hold SPRB as of Q2 2026.

  • JP Morgan Chase held 1,127 shares of Spruce Biosciences worth $63K as of Q2 2026.
  • Spruce Biosciences was a new JP Morgan Chase position in Q2 2026.
  • Spruce Biosciences made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #6330 holding.
  • JP Morgan Chase first reported a position in Spruce Biosciences in Q4 2020 and has held it in 13 quarters since.
  • JP Morgan Chase's Spruce Biosciences position peaked at $4.59M in Q4 2020.
  • 63 funds tracked by Wall St. Rank held Spruce Biosciences as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.